ストックスクリーナーアプリを入手
13.36
2.98%
-0.41
アフターアワーズ：
13.42
0.06
+0.45%
前日終値:
$13.77
開ける：
$13.87
24時間の取引高:
2.63M
Relative Volume:
1.25
時価総額：
$2.03B
収益：
$177.28M
当期純損益:
$-195.24M
株価収益率:
-9.9701
EPS:
-1.34
ネットキャッシュフロー:
$-114.54M
1週間 パフォーマンス:
+5.95%
1か月 パフォーマンス:
+6.37%
6か月 パフォーマンス:
+76.72%
1年 パフォーマンス:
+179.50%
1日の値動き範囲:
$13.26
$13.90
1週間の範囲:
$12.51
$13.90
52週間の値動き範囲:
$3.981
$13.90
Adaptive Biotechnologies Corp Stock (ADPT) Company Profile
名前
Adaptive Biotechnologies Corp
セクター
電話
206-659-0067
住所
1165 EASTLAKE AVE E, SEATTLE, WA
ADPT を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
ADPT
Adaptive Biotechnologies Corp
|
13.36 | 2.10B | 177.28M | -195.24M | -114.54M | -1.34 |
|
VRTX
Vertex Pharmaceuticals Inc
|
383.12 | 99.25B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
591.99 | 63.46B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
453.56 | 59.27B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
736.76 | 44.78B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
334.40 | 37.75B | 3.81B | -644.79M | -669.77M | -6.24 |
Adaptive Biotechnologies Corp Stock (ADPT) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-06-18 | 開始されました | Craig Hallum | Buy |
| 2025-03-21 | アップグレード | Goldman | Neutral → Buy |
| 2023-07-05 | 再開されました | JP Morgan | Overweight |
| 2023-01-05 | 開始されました | Scotiabank | Sector Outperform |
| 2022-12-21 | アップグレード | Piper Sandler | Neutral → Overweight |
| 2022-08-25 | 開始されました | Credit Suisse | Underperform |
| 2022-06-03 | 開始されました | Piper Sandler | Neutral |
| 2022-02-16 | 繰り返されました | BTIG Research | Buy |
| 2022-02-16 | 繰り返されました | BofA Securities | Buy |
| 2022-02-16 | 繰り返されました | Goldman | Neutral |
| 2022-02-16 | 繰り返されました | JP Morgan | Overweight |
| 2021-10-15 | 再開されました | Cowen | Outperform |
| 2021-03-03 | ダウングレード | Goldman | Buy → Neutral |
| 2020-10-08 | 再開されました | BTIG Research | Buy |
| 2020-09-09 | 開始されました | Morgan Stanley | Equal-Weight |
| 2020-06-03 | 開始されました | Goldman | Buy |
| 2019-07-23 | 開始されました | BTIG Research | Buy |
| 2019-07-22 | 開始されました | BofA/Merrill | Buy |
| 2019-07-22 | 開始されました | Cowen | Outperform |
| 2019-07-22 | 開始されました | Goldman | Neutral |
| 2019-07-22 | 開始されました | Guggenheim | Buy |
| 2019-07-22 | 開始されました | William Blair | Outperform |
すべてを表示
Adaptive Biotechnologies Corp (ADPT) 最新ニュース
Statistical indicators supporting Adaptive Biotechnologies Corporation’s strengthQuarterly Profit Review & Reliable Breakout Forecasts - newser.com
Is Adaptive Biotechnologies Corporation stock poised for growthNew Guidance & Breakout Confirmation Trade Signals - newser.com
Identifying reversal signals in Adaptive Biotechnologies Corporation2025 Major Catalysts & Fast Exit and Entry Strategy Plans - newser.com
Can volume confirm reversal in Adaptive Biotechnologies CorporationJuly 2025 Analyst Calls & Accurate Intraday Trade Tips - newser.com
Adaptive Biotechnologies stock hits 52-week high at $13.73 By Investing.com - Investing.com Australia
Adaptive Biotechnologies stock hits 52-week high at $13.73 - Investing.com
Aug Opening: Is Adaptive Biotechnologies Corporation stock good for income investors2025 Fundamental Recap & Precise Swing Trade Entry Alerts - خودرو بانک
Adaptive Biotechnologies Corporation stock retracement – recovery analysisPortfolio Value Report & Expert Approved Momentum Ideas - newser.com
Voya Investment Management LLC Has $14.90 Million Position in Adaptive Biotechnologies Corporation $ADPT - MarketBeat
Adaptive Biotechnologies (NASDAQ:ADPT) Trading 7.5% HigherWhat's Next? - MarketBeat
How sentiment analysis helps forecast Adaptive Biotechnologies Corporation2025 Earnings Surprises & Low Drawdown Investment Strategies - newser.com
Adaptive Biotechnologies Corporation stock trend forecast2025 Performance Recap & Growth-Oriented Investment Plans - newser.com
Tools to assess Adaptive Biotechnologies Corporation’s risk profileWeekly Loss Report & High Conviction Trade Alerts - newser.com
Key metrics from Adaptive Biotechnologies Corporation’s quarterly dataIndex Update & Reliable Intraday Trade Plans - newser.com
Rate Cut: Will Adaptive Biotechnologies Corporation outperform tech stocksJuly 2025 PostEarnings & Weekly Breakout Watchlists - khodrobank.com
Jacobs Levy Equity Management Inc. Sells 33,002 Shares of Adaptive Biotechnologies Corporation $ADPT - MarketBeat
How to manage a losing position in Adaptive Biotechnologies CorporationPortfolio Return Report & Growth-Oriented Investment Plans - newser.com
How to escape a deep drawdown in Adaptive Biotechnologies CorporationEarnings Miss & Real-Time Chart Breakout Alerts - newser.com
Adaptive Biotechnologies (NASDAQ:ADPT) Reaches New 1-Year HighShould You Buy? - MarketBeat
Is Adaptive Biotechnologies Corporation trending in predictive chart modelsEarnings Miss & Weekly High Conviction Trade Ideas - newser.com
Adaptive Biotechnologies (NASDAQ:ADPT) Reaches New 52-Week High – Time to Buy? - Defense World
Adaptive Biotechnologies stock hits 52-week high at $13.53 By Investing.com - Investing.com Nigeria
Published on: 2025-09-12 01:32:59 - Newser
What does recent volatility data suggest for Adaptive Biotechnologies Corporation2025 Market Overview & Verified Swing Trading Watchlists - Newser
Adaptive Biotechnologies stock hits 52-week high at $13.53 - Investing.com
Published on: 2025-09-11 05:04:12 - Newser
How institutional ownership impacts Adaptive Biotechnologies Corporation stockJuly 2025 Reactions & Growth Focused Stock Reports - Newser
Using Python tools to backtest Adaptive Biotechnologies Corporation strategiesPortfolio Return Report & Real-Time Buy Zone Alerts - Newser
Adaptive Biotechnologies at Morgan Stanley Conference: Strategic Growth Insights - Investing.com
Full technical analysis of Adaptive Biotechnologies Corporation stockLayoff News & Long-Term Growth Stock Strategies - Newser
How to forecast Adaptive Biotechnologies Corporation trends using time series2025 Major Catalysts & Smart Money Movement Alerts - Newser
Can Adaptive Biotechnologies Corporation rally from current levelsWeekly Loss Report & Risk Managed Investment Strategies - Newser
Is it too late to sell Adaptive Biotechnologies CorporationMarket Movement Recap & Safe Entry Momentum Tips - Newser
Adaptive Biotechnologies Corp (ADPT) 財務データ
収益
当期純利益
現金流量
EPS
1.43%
0.09%
大文字化:
|
ボリューム (24 時間):